Dodge & Cox’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.11M | Sell |
87,814
-750
| -0.8% | -$19.6K | ﹤0.01% | 164 |
|
|
2026
Q1 | $2.49M | Sell |
88,564
-1,800
| -2% | -$47.9K | ﹤0.01% | 156 |
|
|
2025
Q4 | $2.25M | Sell |
90,364
-2,650
| -3% | -$66.8K | ﹤0.01% | 155 |
|
|
2025
Q3 | $2.37M | Sell |
93,014
-14,946
| -14% | -$369K | ﹤0.01% | 153 |
|
|
2025
Q2 | $2.62M | Sell |
107,960
-1,750
| -2% | -$40.8K | ﹤0.01% | 150 |
|
|
2025
Q1 | $2.78M | Sell |
109,710
-1,850
| -2% | -$48.4K | ﹤0.01% | 141 |
|
|
2024
Q4 | $2.96M | Sell |
111,560
-1,225
| -1% | -$33.2K | ﹤0.01% | 142 |
|
|
2024
Q3 | $3.26M | Sell |
112,785
-3,150
| -3% | -$91.9K | ﹤0.01% | 141 |
|
|
2024
Q2 | $3.24M | Sell |
115,935
-450
| -0.4% | -$12.4K | ﹤0.01% | 137 |
|
|
2024
Q1 | $3.23M | Hold |
116,385
| – | – | ﹤0.01% | 136 |
|
|
2023
Q4 | $3.35M | Sell |
116,385
-2,100
| -2% | -$63.5K | ﹤0.01% | 135 |
|
|
2023
Q3 | $3.93M | Sell |
118,485
-4,500
| -4% | -$159K | ﹤0.01% | 130 |
|
|
2023
Q2 | $4.51M | Sell |
122,985
-500
| -0.4% | -$19.5K | ﹤0.01% | 123 |
|
|
2023
Q1 | $5.04M | Sell |
123,485
-200
| -0.2% | -$8.64K | ﹤0.01% | 123 |
|
|
2022
Q4 | $6.34M | Sell |
123,685
-18,501
| -13% | -$887K | ﹤0.01% | 117 |
|
|
2022
Q3 | $6.22M | Sell |
142,186
-3,699
| -3% | -$180K | ﹤0.01% | 117 |
|
|
2022
Q2 | $7.65M | Hold |
145,885
| – | – | 0.01% | 114 |
|
|
2022
Q1 | $7.55M | Sell |
145,885
-8,467
| -5% | -$439K | ﹤0.01% | 113 |
|
|
2021
Q4 | $9.11M | Sell |
154,352
-1,500
| -1% | -$74.3K | 0.01% | 108 |
|
|
2021
Q3 | $6.7M | Sell |
155,852
-6,069
| -4% | -$269K | ﹤0.01% | 105 |
|
|
2021
Q2 | $6.34M | Sell |
161,921
-6,458
| -4% | -$251K | ﹤0.01% | 107 |
|
|
2021
Q1 | $6.1M | Sell |
168,379
-29,027
| -15% | -$1.03M | ﹤0.01% | 107 |
|
|
2020
Q4 | $7.27M | Sell |
197,406
-29,040
| -13% | -$1.07M | 0.01% | 105 |
|
|
2020
Q3 | $7.88M | Sell |
226,446
-28,187
| -11% | -$988K | 0.01% | 102 |
|
|
2020
Q2 | $7.9M | Sell |
254,633
-70,284
| -22% | -$2.39M | 0.01% | 100 |
|
|
2020
Q1 | $10.1M | Sell |
324,917
-84,564
| -21% | -$2.88M | 0.01% | 95 |
|
|
2019
Q4 | $15.2M | Sell |
409,481
-7,958
| -2% | -$283K | 0.01% | 90 |
|
|
2019
Q3 | $14.2M | Sell |
417,439
-1,238
| -0.3% | -$45K | 0.01% | 89 |
|
|
2019
Q2 | $17.2M | Sell |
418,677
-7,139
| -2% | -$283K | 0.01% | 88 |
|
|
2019
Q1 | $17.2M | Sell |
425,816
-17,542
| -4% | -$703K | 0.01% | 88 |
|
|
2018
Q4 | $18.4M | Sell |
443,358
-13,049
| -3% | -$542K | 0.02% | 89 |
|
|
2018
Q3 | $19.1M | Sell |
456,407
-1,160
| -0.3% | -$44.7K | 0.01% | 90 |
|
|
2018
Q2 | $15.8M | Sell |
457,567
-8,521
| -2% | -$291K | 0.01% | 89 |
|
|
2018
Q1 | $15.7M | Sell |
466,088
-37,019
| -7% | -$1.27M | 0.01% | 89 |
|
|
2017
Q4 | $17.3M | Sell |
503,107
-55,136
| -10% | -$1.88M | 0.01% | 88 |
|
|
2017
Q3 | $18.9M | Sell |
558,243
-48,047
| -8% | -$1.54M | 0.02% | 90 |
|
|
2017
Q2 | $19.3M | Sell |
606,290
-108,396
| -15% | -$3.42M | 0.02% | 85 |
|
|
2017
Q1 | $23.2M | Sell |
714,686
-72,622
| -9% | -$2.29M | 0.02% | 82 |
|
|
2016
Q4 | $24.3M | Sell |
787,308
-27,584
| -3% | -$842K | 0.02% | 85 |
|
|
2016
Q3 | $26.2M | Sell |
814,892
-60,540
| -7% | -$2.02M | 0.02% | 81 |
|
|
2016
Q2 | $29.2M | Sell |
875,432
-104,371
| -11% | -$3.33M | 0.03% | 79 |
|
|
2016
Q1 | $27.6M | Sell |
979,803
-1,384,507
| -59% | -$39.5M | 0.03% | 79 |
|
|
2015
Q4 | $72.4M | Sell |
2,364,310
-45,346,514
| -95% | -$1.43B | 0.07% | 77 |
|
|
2015
Q3 | $1.42B | Buy |
47,710,824
+34,155
| +0.1% | +$1.1M | 1.43% | 28 |
|
|
2015
Q2 | $1.52B | Sell |
47,676,669
-1,626,246
| -3% | -$53M | 1.37% | 29 |
|
|
2015
Q1 | $1.63B | Sell |
49,302,915
-441,219
| -0.9% | -$14M | 1.5% | 25 |
|
|
2014
Q4 | $1.47B | Sell |
49,744,134
-431,515
| -0.9% | -$12.4M | 1.37% | 28 |
|
|
2014
Q3 | $1.41B | Sell |
50,175,649
-1,367,161
| -3% | -$38.4M | 1.35% | 29 |
|
|
2014
Q2 | $1.45B | Sell |
51,542,810
-16,040,742
| -24% | -$457M | 1.38% | 26 |
|
|
2014
Q1 | $2.06B | Sell |
67,583,552
-1,231,912
| -2% | -$36.7M | 2.11% | 18 |
|
|
2013
Q4 | $2B | Sell |
68,815,464
-2,230,918
| -3% | -$64.9M | 2.08% | 17 |
|
|
2013
Q3 | $1.94B | Sell |
71,046,382
-827,773
| -1% | -$22.5M | 2.2% | 15 |
|
|
2013
Q2 | $1.91B | Buy |
+71,874,155
| New | +$1.99B | 2.27% | 14 |
|
Other funds holding PFE
Dodge & Cox's PFE Position: Q2 2026 in Review
Dodge & Cox reduced its Pfizer (PFE) stake by 0.85% in Q2 2026, selling an estimated $19.6K and leaving 87,814 shares worth $2.11M. The position accounts for ﹤0.01% of the portfolio, ranked #164.
Dodge & Cox first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.06B in Q1 2014. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Dodge & Cox held 87,814 shares of Pfizer worth $2.11M as of Q2 2026.
- Dodge & Cox sold 750 Pfizer shares in Q2 2026, an estimated $19.6K.
- Pfizer made up ﹤0.01% of Dodge & Cox's portfolio in Q2 2026, its #164 holding.
- Dodge & Cox first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Dodge & Cox's Pfizer position peaked at $2.06B in Q1 2014.
- 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Dodge & Cox's 13F filing for Q2 2026, filed 13 Aug 2026.